Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 38, 2023 - Issue 1
Submit an article Journal homepage
1,426
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents

Ahmed F. Khalila Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, EgyptCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6887-0836View further author information
ORCID Icon,
Tarek F. El-Moselhya Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, EgyptView further author information
,
Eman A. El-Bastawissya Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, EgyptView further author information
,
Rasha Abdelhadyb Department of Pharmacology and Toxicology, Faculty of Pharmacy, Fayoum University, Fayoum, EgyptORCID Iconhttps://orcid.org/0000-0003-1963-8525View further author information
ORCID Icon,
Nancy S. Younisc Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al Hofuf, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0003-4309-7095View further author information
ORCID Icon &
Mervat H. El-Hamamsya Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, EgyptView further author information
Article: 2157411 | Received 02 Oct 2022, Accepted 05 Dec 2022, Published online: 11 Jan 2023

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Moataz A. Shaldam, Hadia Almahli, Andrea Angeli, Rehab Mustafa Badi, Eman F. Khaleel, Abdelrahman I. Zain-Alabdeen, Zainab M. Elsayed, Eslam B. Elkaeed, Rofaida Salem, Claudiu T. Supuran, Wagdy M. Eldehna & Haytham O. Tawfik. (2023) Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now

Articles from other publishers (4)

Moataz A. Shaldam, Ahmed F. Khalil, Hadia Almahli, Maiy Y. Jaballah, Andrea Angeli, Eman F. Khaleel, Rehab Mustafa Badi, Eslam B. Elkaeed, Claudiu T. Supuran, Wagdy M. Eldehna & Haytham O. Tawfik. (2023) Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity. Archiv der Pharmazie 357:1.
Crossref
Muhammad Imran Ali & Muhammad Moazzam Naseer. (2023) Recent biological applications of heterocyclic hybrids containing s -triazine scaffold . RSC Advances 13:43, pages 30462-30490.
Crossref
Qingyun Wei, Kun Yao, Jie Yang, Qian Zhou, Pengyu Liu, Jiao Chen, Haipeng Liu, Yisheng Lai & Peng Cao. (2023) Structure-Based Drug Design of Novel Triaminotriazine Derivatives as Orally Bioavailable IDH2 R140Q Inhibitors with High Selectivity and Reduced hERG Inhibitory Activity for the Treatment of Acute Myeloid Leukemia . Journal of Medicinal Chemistry 66:18, pages 12894-12910.
Crossref
Hyun-Min Kim, Xiaoyu Zheng & Ethan Lee. (2023) Experimental Insights into the Interplay between Histone Modifiers and p53 in Regulating Gene Expression. International Journal of Molecular Sciences 24:13, pages 11032.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.